JCO Early Release, published online ahead of print Nov 1 2004
Journal of Clinical Oncology, 10.1200/JCO.2004.02.189
Received February 26, 2004
Accepted July 23, 2004
Higher Mortality After Allogeneic Peripheral-Blood Transplantation Compared With Bone Marrow in Children and Adolescents: The Histocompatibility and Alternate Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry
Mary Eapen *, Mary M. Horowitz , John P. Klein , Richard E. Champlin , Fausto R. Loberiza Jr , Olle Ringdén , and John E. Wagner
From the International Bone Marrow Transplant Registry, Health Policy Institute, Medical College of Wisconsin, Milwaukee, WI; The University of Texas M.D. Anderson Cancer Center, Houston, TX; the Karolinska Institutet, Stockholm, Sweden; and the University of Minnesota School of Medicine, Minneapolis, MN.
* To whom correspondence should be addressed. E-mail: meapen{at}mail.mcw.edu
Purpose: Peripheral-blood stem cells (PBSC) may be used as an alternative to bone marrow (BM) for allogeneic transplantation. Despite lack of data on PBSC transplantation in children, there has been a change in clinical practice, with increasing numbers of children receiving PBSC allografts.
Patients and Methods: We compared the results of 143 PBSC and 630 BM transplants from human leukocyte antigen-identical sibling donors in children aged 8 to 20 years with acute leukemia. PBSC transplant recipients were older, and were more likely to have advanced leukemia, receive growth factors post-transplantation, and have undergone transplantation more recently. Risks of acute and chronic graft-versus-host disease (GVHD), treatment-related mortality, relapse, treatment failure (relapse or death), and overall mortality were compared using Cox proportional hazards regression to adjust for potentially confounding factors.
Results: Hematopoietic recovery was faster after PBSC transplantation. Risks of grade 2 to 4 acute GVHD were similar, but chronic GVHD risk was higher after PBSC transplantation (relative risk [RR], 1.85; 95% CI, 1.28 to 2.66; P = .001). In contrast to reports in adults, treatment-related mortality (RR, 1.89; 95% CI, 1.28 to 2.80; P = .001), treatment failure (RR, 1.31; 95% CI, 1.03 to 1.68; P = .03), and mortality (RR, 1.38; 95% CI, 1.07 to 1.79; P = .01) were higher after PBSC transplantation. Risks of relapse were similar.
Conclusion: These data suggest poorer outcomes after PBSC compared with BM transplantation in children after adjusting for relevant risk factors. Given the trend toward increased use of PBSC allografts in children, prospective clinical trials are required to determine their appropriate role in this group of patients.
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Facebook  Reddit  Technorati  Twitter What's this?
Related Editorial
- Allogeneic Peripheral Blood Versus Bone Marrow Transplantation: Children Are Small Adults and More
Donna A. Wall
JCO 2004 22: 4865-4866
[Full Text]
This article has been cited by other articles:
|
|
|
|
 
M. A. Pulsipher, P. Chitphakdithai, B. R. Logan, S. F. Leitman, P. Anderlini, J. P. Klein, M. M. Horowitz, J. P. Miller, R. J. King, and D. L. Confer
Donor, recipient, and transplant characteristics as risk factors after unrelated donor PBSC transplantation: beneficial effects of higher CD34+ cell dose
Blood,
September 24, 2009;
114(13):
2606 - 2616.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Gallardo, R. de la Camara, J. B. Nieto, I. Espigado, A. Iriondo, A. Jimenez-Velasco, C. Vallejo, C. Martin, D. Caballero, S. Brunet, et al.
Is mobilized peripheral blood comparable with bone marrow as a source of hematopoietic stem cells for allogeneic transplantation from HLA-identical sibling donors? A case-control study
Haematologica,
September 1, 2009;
94(9):
1282 - 1288.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. A. Pulsipher, K. M. Boucher, D. Wall, H. Frangoul, M. Duval, R. K. Goyal, P. J. Shaw, A. E. Haight, M. Grimley, S. A. Grupp, et al.
Reduced-intensity allogeneic transplantation in pediatric patients ineligible for myeloablative therapy: results of the Pediatric Blood and Marrow Transplant Consortium Study ONC0313
Blood,
August 13, 2009;
114(7):
1429 - 1436.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G N Samuel, K A Strong, I Kerridge, C F C Jordens, R A Ankeny, and P J Shaw
Establishing the role of pre-implantation genetic diagnosis with human leucocyte antigen typing: what place do "saviour siblings" have in paediatric transplantation?
Arch. Dis. Child.,
April 1, 2009;
94(4):
317 - 320.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Frangoul, E. R. Nemecek, D. Billheimer, M. A. Pulsipher, S. Khan, A. Woolfrey, B. Manes, C. Cole, M. C. Walters, M. Ayas, et al.
A prospective study of G-CSF primed bone marrow as a stem-cell source for allogeneic bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium (PBMTC) study
Blood,
December 15, 2007;
110(13):
4584 - 4587.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Sung, P. C. Nathan, S. M.H. Alibhai, G. A. Tomlinson, and J. Beyene
Meta-analysis: Effect of Prophylactic Hematopoietic Colony-Stimulating Factors on Mortality and Outcomes of Infection
Ann Intern Med,
September 18, 2007;
147(6):
400 - 411.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Schrezenmeier, J. R. Passweg, J. C. W. Marsh, A. Bacigalupo, C. N. Bredeson, E. Bullorsky, B. M. Camitta, R. E. Champlin, R. P. Gale, M. Fuhrer, et al.
Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia
Blood,
August 15, 2007;
110(4):
1397 - 1400.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Sakoda, D. Hashimoto, S. Asakura, K. Takeuchi, M. Harada, M. Tanimoto, and T. Teshima
Donor-derived thymic-dependent T cells cause chronic graft-versus-host disease
Blood,
February 15, 2007;
109(4):
1756 - 1764.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Section on Hematology/Oncology and Section on Alle
Cord Blood Banking for Potential Future Transplantation
Pediatrics,
January 1, 2007;
119(1):
165 - 170.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. C. Fung, M. A. Higman, and K. van Besien
Stem cell transplantation
ASH Self-Assessment Program,
January 1, 2007;
2007(1):
328 - 360.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Dekker, S. Bulley, J. Beyene, L. L. Dupuis, J. J. Doyle, and L. Sung
Meta-Analysis of Randomized Controlled Trials of Prophylactic Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor After Autologous and Allogeneic Stem Cell Transplantation
J. Clin. Oncol.,
November 20, 2006;
24(33):
5207 - 5215.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Aschan
Allogeneic haematopoietic stem cell transplantation: current status and future outlook
Br. Med. Bull.,
October 5, 2006;
(2006)
ldl005v2.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. J. Khoury, F. R. Loberiza Jr, O. Ringden, A. J. Barrett, B. J. Bolwell, J.-Y. Cahn, R. E. Champlin, R. P. Gale, G. A. Hale, A. Urbano-Ispizua, et al.
Impact of posttransplantation G-CSF on outcomes of allogeneic hematopoietic stem cell transplantation
Blood,
February 15, 2006;
107(4):
1712 - 1716.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. C. Lipkin, P. Lenssen, and B. J. Dickson
Nutrition Issues in Hematopoietic Stem Cell Transplantation: State of the Art
Nutr Clin Pract,
August 1, 2005;
20(4):
423 - 439.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. A. Wall
Allogeneic Peripheral Blood Versus Bone Marrow Transplantation: Children Are Small Adults and More
J. Clin. Oncol.,
December 15, 2004;
22(24):
4865 - 4866.
[Full Text]
[PDF]
|
|
|
|
